Community/Retail

A significant number of patients with high low-density lipoprotein (LDL) cholesterol lack prescribed lipid-lowering medications, highlighting gaps in treatment and care practices.

These short-term educational experiences can include specialized courses or training programs.

New research reveals how aging weakens immune responses to RSV in older adults, increasing severity and hospitalization risks.

Because mothers are already at risk of depression postpartum, health care professionals must properly counsel mothers on hormonal contraceptives.

Between December 22, 2024, and March 7, 2025, reported measles cases in the US climbed precipitously.

Research reveals that higher levels of vitamin B12, copper, and manganese during pregnancy lower midlife blood pressure and hypertension risk.

New research highlights the long-lasting effectiveness of mRNA COVID-19 vaccines, showing sustained B-cell and antibody responses in health care workers over 3 years.

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discussed concerns the association has with the implementation of the Medicare Drug Price Negotiation Plan.

This movement has aimed to address the mental health care epidemic in the United States.

Experts attribute the increase of pertussis cases to declining DTaP vaccination rates.

A holistic approach emphasizing lifestyle modifications is essential to maintain weight loss after and while stopping medication.

Invasive pneumococcal disease trends have fluctuated greatly over the past 2 decades, with older adults remaining at the center of disease burden.

An oral dose of 0.6 mg per 5 mL of colchicine could aid individuals who have trouble with swallowing pills.

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP.

By implementing work practices alongside administrative and engineering controls, a safe and healthy work environment can be achieved.

Children who received antibiotics between birth and 2 years of age were more likely to develop food allergies, allergic rhinitis, and asthma, but not neurodevelopmental conditions.

These results suggest that individuals who are immunocompromised with type 2 diabetes (T2D) may need multiple doses of a pneumococcal conjugate vaccine (PCV) to sustain their protection.

Cases have been confirmed in Mexico and Canada.

This shift brings new responsibilities and opportunities, from managing inventory changes to counseling patients on alternative therapies.

The findings suggest a potentially elevated risk of vision impairment with semaglutide (Ozempic, Wegovy; Novo Nordisk) use compared with other weight loss and diabetes medications.

Multiple phase 3 clinical trials demonstrated dupilumab’s (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.

Authors of a review published in The Journal of Allergy and Clinical Immunology emphasized that blood eosinophil count and fractional exhaled nitric oxide cannot be relied on.

Lepodisiran, a small interfering RNA, demonstrated cholesterol-lowering effects at 16-mg, 96-mg, and 400-mg doses, with the highest dose being the most effective.

The recommendations are not considered to be final until they are published in the Morbidity and Mortality Weekly Report.

With a more direct mechanism of action against viral replication compared with standard treatments, the small interfering RNA (siRNA)-based MIR 19 treatment could revolutionize outpatient COVID-19 treatment.